Laura Moreines

Laura Moreines

Auto-generated profile, based on publicly available information

Laura Moreines

New York University , New York City, New York , United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
DSDena Schulman-Green
Dena Schulman-Green
DDDaniel David
Daniel David
LMLaura T. Moreines
Laura T. Moreines
JBJonelle Boafo
Jonelle Boafo
EFEmily Franzosa
Emily Franzosa
MAMelissa D. Aldridge
Melissa D. Aldridge

19 October 2026 in Journal of Palliative Medicine
Verified
Journal Article
Closed access
LMLaura Tycon Moreines
Laura Tycon Moreines
DSDena Schulman-Green
Dena Schulman-Green
SKStuart Katz
Stuart Katz
KMKomal Patel Murali
Komal Patel Murali
CMChenjuan Ma
Chenjuan Ma
ABAbraham A. Brody
Abraham A. Brody
Background: Heart failure (HF) and Alzheimer’s disease and related dementias (AD/ADRD) frequently co-occur, complicating medication management at the end of life. Methods: This secondary analysis included 1338 patients with HF and AD/ADRD across 12 hospices. HF was classified as a primary ( n = 210) or secondary ( n = 1128). HF-related medication use and discontinuation at hospice admission were characterized and compared by diagnosis primacy. Results: Prehospice use was highest for beta-blockers (44.0%), loop diuretics (32.4%), and renin-angiotensin-aldosterone system (RAAS) inhibitors (17.7%). Among patients with documented use, discontinuation was 91.2%–100% across medication classes, including beta-blockers (97.5%), loop diuretics (97.0%), and RAAS inhibitors (94.1%). Discontinuation did not differ by HF diagnostic primacy. Conclusions: HF-related medication discontinuation was common at hospice admission among patients with HF and AD/ADRD, regardless of HF diagnostic primacy. Further research is needed to understand the clinical rationale and symptom outcomes associated with medication discontinuation in hospice.

1 December 2023 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
DDDaniel David
Daniel David
JBJonelle Boafo
Jonelle Boafo
PKPatricia Kim
Patricia Kim
LMLaura Moreines
Laura Moreines
EFEmily Franzosa
Emily Franzosa
MAMelissa Aldridge
Melissa Aldridge
The provision of care to older adults with serious illness through home hospice visits was extremely challenging for interdisciplinary teams during the COVID-19 pandemic in NYC. We interviewed 20 interdisciplinary providers (nurses, managers, administrators, physicians, medical directors, social workers, and clergy) from three organizations that provided end-of-life care in-person and through telehealth to older adults and their caregivers in NYC. Qualitative content analysis was used to identify themes, categorize findings, and identify important adaptations that were required to provide hospice care during the pandemic. Findings reveal how organizations, providers, patients, and families contended with fear, communicated challenges, and adapted to an ever-changing regulatory landscape. The experience of providing care was markedly different for those who were required to deliver care in person vs. by telehealth. Difficult care choices were made impacting access and the services offered by hospice organizations. Salient themes included: organizational challenges – “building a plane while it’s taking off” (e.g., implementing institutional safety protocols with imperfect COVID-19 information to a wary staff), patient/family challenges – “you aren’t coming in my home” (e.g., inability to enroll patients into hospice without a face-to-face visit), and provider challenges – “some things you can’t do through telehealth.” (e.g., telehealth is a vastly inferior medium to teach isolated family caregivers how to provide end-of-life support to dying family members). These findings provide an opportunity to consider the unique qualities of hospice care, what care can and cannot be effectively delivered through virtual modalities, and what effective adaptations may be sustained long-term.

1 December 2023 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
PKPatricia Kim
Patricia Kim
EFEmily Franzosa
Emily Franzosa
LMLaura Moreines
Laura Moreines
JBJonelle Boafo
Jonelle Boafo
DDDaniel David
Daniel David
MAMelissa Aldridge
Melissa Aldridge
Many patients and families rely on paid aides to provide personal care services at the end of life, but the COVID-19 pandemic caused widespread delays and disruption in this care. Our study examined COVID-related care disruptions among patients in a large, New York City health system who died between March 1, 2020 and March 1, 2021. We linked the electronic health records of 124 patients cared for by a geriatric outpatient practice and referred to hospice to the hospice’s electronic health records, and conducted an in-depth qualitative thematic analysis. We found many home health aides continued caring for existing patients after hospice enrollment, often in tandem with hospice aides. But, patients and families experienced disruption in both usual and hospice aide services due to patient or aide illness, COVID isolation policies, and the exacerbation of ongoing workforce shortages. Aides experienced emotional strain and escalation of care responsibilities including the provision of more clinically-focused end-of-life tasks (e.g., wound care, oxygen administration) usually performed by hospice nurses. When the hospice team was unable to provide home visits, the aide became the primary source of patient information. Hospice staff supported aides in care tasks and provided emotional and spiritual care, often virtually, to aides and patients’ families. Findings highlight the critical role of aides within the care team and its intensification in a crisis, suggesting opportunities to better integrate aides into hospice care teams while providing formal training and support to help aides manage end of life care tasks and emotional demands.

1 December 2023 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
LMLaura Moreines
Laura Moreines
JBJonelle Boafo
Jonelle Boafo
EFEmily Franzosa
Emily Franzosa
PKPatricia Kim
Patricia Kim
DSDena Schulman-Green
Dena Schulman-Green
DDDaniel David
Daniel David
COVID-19 illuminated many of the inequities that exist in the current healthcare system, especially for those who are most vulnerable and facing the end of life. Social determinants of health (SDOH) directly and indirectly influence access to the quality of care received by patients enrolled on the hospice benefit. We interviewed 20 interdisciplinary providers (nurses, managers, administrators, physicians, medical directors, social workers, and clergy) between September 2022 and January 2023 from three healthcare organizations that provided hospice care to older adults and their caregivers in NYC regarding their perceptions of the impact of SDOH on the delivery of hospice care during the pandemic. We then conducted rapid analysis of their responses. Findings emerged around three salient themes: 1. “I provide equal care to everyone” (Some providers recognize SDOH result in inequities within hospice, whereas others perceive hospice as an equalizer of care); 2. “They’re going to kill us” (Describing barriers that challenge hospice enrollment and continued access to care); and 3. “We’ve got to do better” (Addressing inequity through organizational and community programs that address barriers and improve access to hospice). Overall, we learned that SDOH must be addressed in a proactive rather than a reactive way to ensure hospice access. Systemic, rather than individual approaches were needed to overcome existing barriers exacerbated by the pandemic. To this end we will discuss lessons learned and strategies for program development and equitable delivery of home hospice care.